Aida Habtezion, MD
Gastroenterology · Stanford
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Habtezion’s office at (650) 725-6511 to ask if they take your plan before you enroll.
California Medical Board record
Licence A83654 · Current
Licensed to practise in California · since 2003 · expires 2027-01-31 · Mcmaster University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Money from drug and device companies
$9,065 in 2020
| 2020 | 1 | 18 | $8,000 | $9,065 |
| 2019 | 3 | 17 | $19,280 | $19,794 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Takeda Pharmaceuticals U.S.A. | None | $9,065 | 18 payments
|
See all 18 published payments
| Takeda Pharmaceuticals U.S.A. | Consulting · 2020-03-24 | None | $8,000 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-27 | None | $16 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-27 | None | $4 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-27 | None | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-27 | None | $12 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2020-02-27 | None | $43 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2020-02-26 | None | $237 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-26 | None | $18 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-26 | None | $6 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-26 | None | $25 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-26 | None | $4 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-26 | None | $14 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-26 | None | $108 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2020-02-26 | None | $14 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2020-02-25 | None | $112 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2020-02-25 | None | $32 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2020-02-25 | None | $164 |
| Takeda Pharmaceuticals U.S.A. | Travel · 2020-02-25 | None | $237 |
See earlier years (2019)
2019: $19,794
| Genentech | Non-Covered Product | $10,800 | 8 payments
|
| Gilead Sciences | None | $8,939 | 8 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $54 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Genentech, Inc. · Understanding the Role of Cd103 in Inflammatory Bowel Disease · 2020 | Their institution | $225,000 |
| Takeda Pharmaceuticals U.S.A., Inc. · Immunoinflammatory Effect of Prior Exposure To Anti-Tnf Therapy · 2020 | Their institution | $44,986 |
| Genentech, Inc. · Understanding the Role of Cd103 in Inflammatory Bowel Disease · 2021 | Their institution | $42,226 |
Professional record
- NPI
- 1902109796
- Licence
- CA A83654California A83654: Current · expires 2027-01-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 300 Pasteur Dr, Alway Bldg, Room M-211, Stanford, CA, 94305
- NPI first listed
- 2010-12-16
- NPI last updated
- 2010-12-16
This is when the NPI record was last certified, not a medical board exam.